Intranasal Dexmedetomidine Versus Intranasal Midazolam as a Premedication in Pediatrics Undergoing Upper GI Endoscopy

• Status: Not yet recruiting
• Trial end date: 2024-03-01
• Target enrollment: 0
• Participant gender: All

Summary

compare the effectiveness of intranasal dexmedetomidine and midazolam as a premedication in sedation of preschool children in GI endoscopy

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams University
• Treatments: Dexmedetomidine; Midazolam

Criteria

Inclusion Criteria:

• Children of preschool age (2-6 years old).

• American scocity of anaesthesiology (ASA) I - II children.

• Expected duration of the procedure is less than 50 minutes.

Exclusion Criteria:

• Cardiac arrhythmia, congenital heart disease, or hemodynamic or respiratory instability; children at risk for airway obstruction.

• Behavioral, mental or developmental abnormality (example: mental retardation, Attention Deficit Hyperactivity Disorder "ADHD", Autism, Down syndrome).

• Regular intake of either brain stimulant or depressive drugs (example:

Methylphenidate, amphetamine-dextroamphetamine and diazepam respectively).

• Parent's refusal.

• Emergency case.

• Allergy to any of the used drugs